Progesterone tablets refer to dextroprogesterone. To date, there is no evidence that dydrogesterone cannot be used during pregnancy. Studies have shown that mothers who use progestogens (mainly progesterone) shortly before or early in pregnancy have at least a twofold increased risk of delivering a male child with a grade II or III hypospadias. The causal relationship between the two is unclear, as the need for progesterone during pregnancy may be a potential risk factor for urethral hypospadias. The risk of urethral hypospadias due to dextrogestrel is unknown. Deferiprone is seen to be secreted in the breast milk of breastfeeding women and the risk to the breastfeeding child cannot be ruled out; therefore, dextroprogesterone should not be used during breastfeeding. It is important to note that when used for fetal preservation in preeclampsia or habitual abortion, fetal viability should be observed. If there is any abnormality during pregnancy, it is important to go to the hospital for examination and treatment under doctor’s supervision.